Showing 14 of 34 recruiting trials for “juvenile-idiopathic-arthritis”
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
👨⚕️ Megan L Fitzgerald, PhD, Brain Inflammation Collaborative📍 1 site📅 Started Jul 2023View details ↗
Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA
👨⚕️ Lori B Tucker, MD, University of British Columbia Department of Pediatrics📍 1 site📅 Started May 2023View details ↗
RecruitingNCT05534347 ↗
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
👨⚕️ Yannick ALLANORE, PD, PhD, Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT05176795 ↗
Host-microbiota-environment Interactions
RecruitingNCT06007456 ↗
Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis
👨⚕️ Serena Pastore, MD, IRCCS materno infantile Burlo Garofolo📍 2 sites📅 Started Jan 2022View details ↗
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 55 sites📅 Started Feb 2020View details ↗
Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST, Eli Lilly and Company📍 82 sites📅 Started Apr 2019View details ↗
RecruitingNCT06560606 ↗
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
👨⚕️ Rae SM Yeung, MD, PhD, FRCPC, The Hospital for Sick Children (SickKids), University of Toronto📍 19 sites📅 Started Aug 2018View details ↗
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
RecruitingNCT03245801 ↗
CAPRI National Juvenile Idiopathic Arthritis Registry
👨⚕️ Jaime Guzman, MD, FRCPC, University of British Columbia📍 15 sites📅 Started Feb 2017View details ↗
RecruitingNCT07000916 ↗
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
RecruitingNCT01422694 ↗
Natural History and Development of Spondyloarthritis
👨⚕️ Sahar Lotfi-Emran, M.D., National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)📍 1 site📅 Started Aug 2011View details ↗
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →